-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Elevance Health, Raises Price Target to $449

Benzinga·10/22/2026 17:45:57
语音播报
Morgan Stanley analyst Erin Wright maintains Elevance Health (NYSE:ELV) with a Equal-Weight and raises the price target from $404 to $449.